Although our analysis indicates that elevated KDM4B expression in CRC patients predicts poor survival (Figure 5C), we suspect that KDM4B exerts its pro-oncogenic effects solely via activating TCL transcription. This evidence concerns the gene KDM4B and colorectal carcinoma.